Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial
University of Pennsylvania · Royal Marsden Hospital · +14 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,625
total citations
- FWCI
- 93.41
- Percentile
- 100%
- References
- 33
Citations per year
Authors
17- MSMarcia S. BroseCorresponding
University of Pennsylvania
- CMChristopher M. Nutting
Royal Marsden Hospital
- BJBarbara Jarząb
The Maria Sklodowska-Curie National Research Institute of Oncology
- RERossella Elisei
University of Pisa
- SSSalvatore Siena
Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda
Topics & keywords
Topics
Keywords
- Sorafenib
- Medicine
- Radioactive iodine
- Thyroid cancer
- Refractory (planetary science)
- Oncology
- Internal medicine
- Double blind
No related works found for this paper.